HomeEVGN • NASDAQ
add
Evogene Ltd
Previous close
$1.05
Day range
$1.02 - $1.06
Year range
$0.95 - $2.42
Market cap
9.11M USD
Avg Volume
49.16K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
.INX
0.32%
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 312.00K | -82.63% |
Operating expense | 2.88M | -64.76% |
Net income | 3.87M | 150.77% |
Net profit margin | 1.24K | 392.27% |
Earnings per share | -0.46 | 64.51% |
EBITDA | -2.44M | 64.22% |
Effective tax rate | -0.04% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 15.96M | -20.02% |
Total assets | 26.09M | -34.97% |
Total liabilities | 8.83M | -68.31% |
Total equity | 17.25M | — |
Shares outstanding | 8.72M | — |
Price to book | 8.04 | — |
Return on assets | -22.70% | — |
Return on capital | -39.13% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | 3.87M | 150.77% |
Cash from operations | -3.33M | 32.37% |
Cash from investing | 10.91M | 441.12% |
Cash from financing | -10.34M | -318.34% |
Net change in cash | -2.70M | -247.46% |
Free cash flow | -385.62K | -131.18% |
About
Evogene is a computational chemistry company based in Israel, specializing in the generative design of small molecules for the pharmaceutical and agricultural industries. At the core of its technology is ChemPass AI, a proprietary generative AI engine that enables the design of novel, highly potent small molecules optimized across multiple critical parameters. This powerful platform significantly improves success rates while reducing development time and costs. Built on this powerful technological foundation, and through strategic partnerships alongside internal product development, Evogene is focused on creating breakthrough products driven by the integration of scientific innovation with real-world industry needs.
In 2024, the company began collaborating with Google Cloud to develop an AI-powered generative model aimed at discovering small molecules for drug development and sustainable agriculture. Wikipedia
CEO
Founded
1999
Website
Employees
117